Real-time enrollment status for this borderline resectable pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 10:15 AM UTC
| NCT Number | NCT07619313 |
| Recruiting Status | Recruiting |
| Condition | Borderline Resectable Pancreatic Ductal Adenocarcinoma |
| Phase | PHASE1 |
| Target Enrollment | 46 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Jonsson Comprehensive Cancer Center |
| Last Updated on CT.gov | August 20, 2026 (1 week ago) |
As of September 2, 2026: Clinical trial NCT07619313 is currently recruiting participants. This phase1 study for borderline resectable pancreatic ductal adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Jonsson Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07619313 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07619313 was last updated 1 week ago (August 20, 2026). HelloStudys verifies this status automatically.